ISMP
ISMP
Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP
ISMP
ISMP Facebook
Site Search by PicoSearch. Help

The full version of the newsletter is available by subscription
Back issues of the newsletter to January 1996 are available on CD-ROM.


July 13, 2006

Instructions and labeling of the new inhaled insulin, EXUBERA (insulin human [rDNA]), poses serious risk of dosing errors.

  • Acute phosphate nephropathy.

The FDA recently notified healthcare professionals and consumers regarding reports of acute phosphate nephropathy associated with oral sodium phosphates used for bowel cleansing.

  • Using technician errors as an opportunity for change.

A survey of over 800 pharmacy technicians reported that interruptions and inadequate staffing were among the most frequent factors perceived to contribute to technician medication preparation errors.

  • Community education

Partnering of Patient Empowerment Through Community Awareness (PPECA) has created a free program for educating consumers about healthcare safety.

Special Announcements…

Join ISMP for our August 3 teleconference, 2006-2007 JC Update: Requirements Related to Medication Use.  The teleconference will be repeated on August 10.

  • Webinar

The Nursing Leadership Congress is sponsoring a free webinar on August 2 entitled, Using Human Centered Design to Improve Patient Safety. The program is intended for senior nursing leaders and explores the nurses’ role in designing safe practices. For details visit: www.nursingleadershipcongress.com/nursingcongress/webinars.asp


July 27, 2006

Infusion pump “double keying” errors have been reported with various types of pumps. We recently learned about a double keying incident that resulted in infusion of TPN at 445 mL/hr, instead of 45 mL/hr, for 4 hours before a rapid response team uncovered the error.

  • Luer accepts oral syringe

When the right amount of force is applied, BD Q-SYTE Luer Access Split-System Devices, used to cap peripheral and central venous access lines, have the potential to be accessed by an oral syringe.

  • “Triptans” and SSRIs/SNRIs

FDA notified health professionals and consumers last week about the risk of serotonin syndrome when combining 5-hydroxytryptamine receptor agonists (triptans) with selective serotonin reuptake inhibitors (SSRIs) and selective serotonin/norepinephrine reuptake inhibitors (SNRIs).

  • Inhaled insulin delayed

The release of EXUBERA inhalation powder (insulin human [rDNA origin]) will be delayed until September to allow more time for provider education.

  • ISMP Quarterly Action Agenda

The April-June 2006 ISMP Quarterly Action Agenda appears in the PDF version of the newsletter. Subscribers can also download a Word version of the Action Agenda (www.ismp.org/Newsletters/acutecare/actionagenda.doc), which allows expansion of the boxes designated for organizational documentation of an assessment, actions required, and assignments for each agenda item.

Special Announcements…

Join ISMP for our August 3 teleconference, 2006-2007 JC Update: Requirements Related to Medication Use.  The teleconference will be repeated on August 10.

  • Webinar

The Nursing Leadership Congress is sponsoring a free webinar on August 2 entitled, Using Human Centered Design to Improve Patient Safety. The program is intended for senior nursing leaders and explores the nurses’ role in designing safe practices. For details visit: www.nursingleadershipcongress.com/nursingcongress/webinars.asp

subscribe now

Resources
Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Survey Results
Action Agendas - Free CEs
Special Error Alerts
Subscribe
Newsletter Editions
Acute Care
Community/Ambulatory
Nursing
Long Term Care
Consumer
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officer Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2014 Institute for Safe Medication Practices. All rights reserved

 
ISMP
ISMP